Type 2 Diabetes Research Study
Do You Have Type 2 Diabetes?
NOW ENROLLING FOR A LOCAL INVESTIGATIONAL STUDY
A member of our staff will be in contact with you shortly.
Have you tried everything, and are still searching for a solution to managing your Type 2 Diabetes? Clinvest is investigating a new option, but we need your participation to explore new horizons in health.
We are searching for Springfield area applicants to participate in a clinical research study to potentially improve options for those diagnosed with Type 2 Diabetes. The goal of this study is to assess an investigational medication for Diabetes. If you’ve ever wished there were more treatment options, then we ask for your help in researching this possibility!
WHAT SHOULD I EXPECT?
Dr. True and Clinvest are seeking volunteers who have Type 2 diabetes treated either with lifestyle or various diabetic regimens, have an elevated HbA1c at screening and have established cardiovascular, cerebrovascular or peripheral arterial disease. This is an international Phase 3, randomized, double-blind trial to assess the effectiveness of weekly investigational study drug (up to 15 mg) compared to weekly dulaglutide (1.5 mg) when added to the standard of care.
Qualified subjects who complete a 2-week screening period may be deemed eligible to begin a 24 week dose escalation period, with clinic visits every 2 weeks followed by a maintenance period with clinic visits every 3 months until the number of sponsor-determined endpoints are reached (approx. 48 months). All study-related procedures and study drug, including standard of care for diabetes & cardiovascular disease will be provided at no cost to you. Compensation will be provided at each completed visit for your time and travel. You may be provided reimbursement for mileage, fasting meals, and public transportation.
TO FIND OUT MORE
LEARN MORE ABOUT OUR STUDIES
Clinvest Research is a clinical investigation company based in southwest Missouri. We are constantly seeking participants for clinical trials in order to further options for sufferers of various conditions. Our doctors are a part of a select group of clinics in the U.S. that have been involved in over 200 Phase II-IV clinical research studies sponsored primarily by the pharmaceutical industry or studies created by doctors after patient observation.
Study visits are conducted via outpatient and do not require overnight stays. In fact, we pride ourselves in making your participation in the studies as easy and convenient as possible.
If you qualify and choose to join a study, you will be treated by our team of specialists and may receive study-related care at no cost. Call us at (417) 883-7889 to learn more.